Astellas Pharma Inc. (ALPMF)
OTC: ALPMF
· Real-Time Price · USD
11.10
0.00 (0.00%)
At close: Sep 26, 2025, 9:32 AM
11.10
0.00%
After-hours: Oct 01, 2025, 08:00 PM EDT
Astellas Pharma Revenue
Astellas Pharma reported an annual revenue of $1,912.3B, reflecting a 19.25% growth. For the quarter ending March 31, 2025, Astellas Pharma generated $459.29B in revenue.
Revenue (ttm)
1,912.3B
Revenue Growth
19.25%
Price / Sales Ratio
1.37
Revenue / Employee
129.61M
Employees
14,754
Market Cap
19.87B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Mar 31, 2025 | 1,912.3B | +19.25% |
| Mar 31, 2024 | 1,603.7B | +5.60% |
| Mar 31, 2023 | 1,518.6B | +17.16% |
| Mar 31, 2022 | 1,296.2B | +3.73% |
| Mar 31, 2021 | 1,249.5B | -3.94% |
| Mar 31, 2020 | 1,300.8B | -0.42% |
| Mar 31, 2019 | 1,306.3B | +0.46% |
| Mar 31, 2018 | 1,300.3B | -0.87% |
| Mar 31, 2017 | 1,311.7B | -4.45% |
| Mar 31, 2016 | 1,372.7B | +10.06% |
| Mar 31, 2015 | 1,247.3B | +9.42% |
| Mar 31, 2014 | 1,139.9B | +13.35% |
| Mar 31, 2013 | 1,005.6B | +3.74% |
| Mar 31, 2012 | 969.39B | +1.62% |
| Mar 31, 2011 | 953.95B | -2.15% |
| Mar 31, 2010 | 974.88B | +0.95% |
| Mar 31, 2009 | 965.7B | -0.71% |
| Mar 31, 2008 | 972.59B | +5.64% |
| Mar 31, 2007 | 920.62B | +4.69% |
| Mar 31, 2006 | 879.36B | +96.70% |
| Mar 31, 2005 | 447.05B | -12.55% |
| Mar 31, 2004 | 511.21B | n/a |